Literature DB >> 8305528

Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy.

A Holmberg1, L Meurling.   

Abstract

This study presents a carrier system for boron, potentially useful in boron neutron capture therapy (BNCT). Na2B12H11SH (BSH) was covalently coupled to dextran derivatives. This was accomplished in two ways. The first method comprises activation of dextran with 1-cyano-4-(dimethylamino)pyridine (CDAP) with subsequent coupling of 2-aminoethyl pyridyl disulfide (method A). The thiolated dextran could then couple BSH in a disulfide exchange reaction. In the second procedure, dextran was derivatized to a multially derivative (method B) which reacted with BSH in a free-radical-initiated addition reaction. The assessment of boron content of the conjugates was done by elemental analysis of sulfur and atomic spectroscopy of boron (ICP-AES). With method A, only limited numbers of boron cages could be coupled (10-20 cages per dextran chain). With method B, 100-125 boron cages per dextran chain was obtained, corresponding to 1200-1500 boron atoms per dextran chain. This result makes this derivative a promising template for use in the development of BNCT agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305528     DOI: 10.1021/bc00024a023

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  2 in total

Review 1.  Targeted drug delivery for boron neutron capture therapy.

Authors:  S C Mehta; D R Lu
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

2.  Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection.

Authors:  Alessandra Boschi; Micòl Pasquali; Claudio Trapella; Alessandro Massi; Petra Martini; Adriano Duatti; Remo Guerrini; Vinicio Zanirato; Anna Fantinati; Erika Marzola; Melchiore Giganti; Licia Uccelli
Journal:  Pharmaceuticals (Basel)       Date:  2018-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.